Temporal SILAC-based quantitative proteomics identifies host factors involved in chikungunya virus replication

Proteomics

Volumn 15, Issue 13, 2015, Pages 2267-2280

  Treffers, Emmely E ^a   Tas, Ali ^a   Scholte, Florine E M ^a   Van, Myrthe N ^a   Heemskerk, Matthias T ^a   de Ru, Arnoud H ^a   Snijder, Eric J ^a   van Hemert, Martijn J ^a   van Veelen, Peter A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alphavirus; Chikungunya virus; Microbiology; SILAC; Temporal proteomics; Virus host interactions

Indexed keywords

DEAD BOX PROTEIN 56; HOST FACTOR; POLO LIKE KINASE 1; RNA POLYMERASE II; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CHIKUNGUNYA VIRUS; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STABLE ISOTOPE LABELING BY AMINO ACID IN CELL CULTURE; TANDEM MASS SPECTROMETRY; TEMPORAL ANALYSIS; VIRUS REPLICATION; CELL LINE; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; PHYSIOLOGY;

ALPHAVIRUS; ARTHROPODA; CHIKUNGUNYA VIRUS;

CELL LINE; CHIKUNGUNYA VIRUS; HUMANS; MICROSCOPY, FLUORESCENCE; PROTEOMICS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84933671071     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400581     Document Type: Article

References (68)

1. Burt, F. J., Rolph, M. S., Rulli, N. E., Mahalingam, S., Heise, M. T., Chikungunya: a re-emerging virus. Lancet 2012, 379, 662-671.
2. Gould, E. A., Gallian, P., DeLamballerie, X., Charrel, R. N., First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clin. Microbiol. Infection 2010, 16, 1702-1704.
3. Rezza, G., Nicoletti, L., Angelini, R., Romi, R. et al., Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007, 370, 1840-1846.
4. Fischer, M., Staples, J. E., Notes from the field: chikungunya virus spreads in the Americas-Caribbean and South America, 2013-2014. MMWR 2014, 63, 500-501.
5. McCarthy, M., First case of locally acquired chikungunya is reported in US. BMJ 2014, 349, g4706.
6. Strauss, J. H., Strauss, E. G., The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 1994, 58, 491-562.
7. Gould, E. A., Coutard, B., Malet, H., Morin, B. et al., Understanding the alphaviruses: recent research on important emerging pathogens and progress towards their control. Antiviral Res. 2010, 87, 111-124.
8. Frolova, E. I., Fayzulin, R. Z., Cook, S. H., Griffin, D. E. et al., Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J. Virol. 2002, 76, 11254-11264.
9. Kaariainen, L., Ranki, M., Inhibition of cell functions by RNA-virus infections. Ann. Rev. Microbiol. 1984, 38, 91-109.
10. Parashar, D., Cherian, S., Antiviral perspectives for chikungunya virus. BioMed. Res. Int. 2014, 2014, 631642.
11. Prussia, A., Thepchatri, P., Snyder, J. P., Plemper, R. K., Systematic approaches towards the development of host-directed antiviral therapeutics. Int. J. Mol. Sci. 2011, 12, 4027-4052.
12. Ma-Lauer, Y., Lei, J., Hilgenfeld, R., vonBrunn, A., Virus-host interactomes-antiviral drug discovery. Curr. Opinion Virol. 2012, 2, 614-621.
13. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
14. Smith, D. R., Global protein profiling studies of chikungunya virus infection identify different proteins but common biological processes. Rev. Med. Virol. 2015, 25, 3-18.
15. Dhanwani, R., Khan, M., Alam, S. I., Rao, P. V., Parida, M., Differential proteome analysis of chikungunya virus-infected new-born mice tissues reveal implication of stress, inflammatory and apoptotic pathways in disease pathogenesis. Proteomics 2011, 11, 1936-1951.
16. Dhanwani, R., Khan, M., Lomash, V., Rao, P. V. et al., Characterization of chikungunya virus induced host response in a mouse model of viral myositis. PloS One 2014, 9, e92813.
17. Issac, T. H., Lee, T. E., Chu, J. J., Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication. J. Proteomics 2014, 108, 445-464.
18. Thio, C. L., Yusof, R., Abdul-Rahman, P. S., Karsani, S. A., Differential proteome analysis of chikungunya virus infection on host cells. PloS One 2013, 8, e61444.
19. Abere, B., Wikan, N., Ubol, S., Auewarakul, P. et al., Proteomic analysis of chikungunya virus infected microgial cells. PloS One 2012, 7, e34800.
20. Wikan, N., Khongwichit, S., Phuklia, W., Ubol, S. et al., Comprehensive proteomic analysis of white blood cells from chikungunya fever patients of different severities. J. Transl. Med. 2014, 12, 96.
21. Puttamallesh, V. N., Sreenivasamurthy, S. K., Singh, P. K., Harsha, H. C. et al., Proteomic profiling of serum samples from chikungunya-infected patients provides insights into host response. Clin. Proteomics 2013, 10, 14.
22. Fraisier, C., Koraka, P., Belghazi, M., Bakli, M. et al., Kinetic analysis of mouse brain proteome alterations following chikungunya virus infection before and after appearance of clinical symptoms. PloS One 2014, 9, e91397.
23. Garmashova, N., Gorchakov, R., Volkova, E., Paessler, S. et al., The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J. Virol. 2007, 81, 2472-2484.
24. Kamitani, W., Narayanan, K., Huang, C., Lokugamage, K. et al., Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc. Natl. Acad. Sci. USA 2006, 103, 12885-12890.
25. McGinnis, S., Madden, T. L., BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res. 2004, 32, W20-W25.
26. Chou, H. H., Takematsu, H., Diaz, S., Iber, J. et al., A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc. Natl. Acad. Sci. USA 1998, 95, 11751-11756.
27. Yim, H., Erikson, R. L., Cell division cycle 6, a mitotic substrate of polo-like kinase 1, regulates chromosomal segregation mediated by cyclin-dependent kinase 1 and separase. Proc. Natl. Acad. Sci. 2010, 107, 19742-19747.
28. Okamoto, Y., Ozaki, T., Miyazaki, K., Aoyama, M. et al., UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res. 2003, 63, 4167-4173.
29. vanKasteren, P. B., Bailey-Elkin, B. A., James, T. W., Ninaber, D. K. et al., Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc. Natl. Acad. Sci. USA 2013, 110, E838-E847.
30. Scholte, F. E., Tas, A., Martina, B. E., Cordioli, P. et al., Characterization of synthetic chikungunya viruses based on the consensus sequence of recent E1-226V isolates. PloS One 2013, 8, e71047.
31. Wisniewski, J. R., Zougman, A., Nagaraj, N., Mann, M., Universal sample preparation method for proteome analysis. Nat. Methods 2009, 6, 359-362.
32. Horth, P., Miller, C. A., Preckel, T., Wenz, C., Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis. Mol. Cell. Proteomics 2006, 5, 1968-1974.
33. Hubner, N. C., Ren, S., Mann, M., Peptide separation with immobilized pI strips is an attractive alternative to in-gel protein digestion for proteome analysis. Proteomics 2008, 8, 4862-4872.
34. Meiring, H. D., vander Heeft, E., ten Hove, G. J., deJong, A., Nanoscale LC-MS(n): technical design and applications to peptide and protein analysis. J. Sep. Sci. 2002, 25, 557-568.
35. Cox, J., Mann, M., MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26, 1367-1372.
36. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A. et al., Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 2011, 10, 1794-1805.
37. Schwanhausser, B., Busse, D., Li, N., Dittmar, G. et al., Global quantification of mammalian gene expression control. Nature 2011, 473, 337-342.
38. Kearse, M., Moir, R., Wilson, A., Stones-Havas, S. et al., Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 2012, 28, 1647-1649.
39. Utt, A., Das, P. K., Varjak, M., Lulla, V. et al., Mutations conferring a non-cytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of non-structural protein 2. J. Virol. 2015, 89, 3145-3162.
40. Scholte, F. E., Tas, A., Albulescu, I. C., Zusinaite, E. et al., Stress granule components G3BP1 and G3BP2 play a proviral role early in chikungunya virus replication. J. Virol. 2015, 89, 4457-4469.
41. Metz, S. W., Geertsema, C., Martina, B. E., Andrade, P. et al., Functional processing and secretion of chikungunya virus E1 and E2 glycoproteins in insect cells. Virol. J. 2011, 8, 353.
42. Vellinga, J., deVrij, J., Myhre, S., Uil, T. et al., Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid. Gene Ther. 2007, 14, 664-670.
43. Pichlmair, A., Reise Sousa, C., Innate recognition of viruses. Immunity 2007, 27, 370-383.
44. White, L. K., Sali, T., Alvarado, D., Gatti, E. et al., Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff. J. Virol. 2011, 85, 606-620.
45. Gibbs, R. A., Rogers, J., Katze, M. G., Bumgarner, R. et al., Evolutionary and biomedical insights from the rhesus macaque genome. Science 2007, 316, 222-234.
46. Chardin, P., Function and regulation of Rnd proteins. Nat. Rev. 2006, 7, 54-62.
47. Frolova, E., Gorchakov, R., Garmashova, N., Atasheva, S. et al., Formation of nsP3-specific protein complexes during Sindbis virus replication. J. Virol. 2006, 80, 4122-4134.
48. Spuul, P., Balistreri, G., Kaariainen, L., Ahola, T., Phosphatidylinositol 3-kinase-, actin-, and microtubule-dependent transport of Semliki Forest Virus replication complexes from the plasma membrane to modified lysosomes. J. Virol. 2010, 84, 7543-7557.
49. Villalonga, P., Fernandez de Mattos, S., Ridley, A. J., RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation. J. Biol. Chem. 2009, 284, 35287-35296.
50. Jarmoskaite, I., Russell, R., RNA helicase proteins as chaperones and remodelers. Ann. Rev. Biochem. 2014, 83, 697-725.
51. Zirwes, R. F., Eilbracht, J., Kneissel, S., Schmidt-Zachmann, M. S., A novel helicase-type protein in the nucleolus: protein NOH61. Mol. Biol. Cell 2000, 11, 1153-1167.
52. Thomas, S., Rai, J., John, L., Schaefer, S. et al., Chikungunya virus capsid protein contains nuclear import and export signals. Virol. J. 2013, 10, 269.
53. Xu, Z., Anderson, R., Hobman, T. C., The capsid-binding nucleolar helicase DDX56 is important for infectivity of West Nile virus. J. Virol. 2011, 85, 5571-5580.
54. Xu, Z., Hobman, T. C., The helicase activity of DDX56 is required for its role in assembly of infectious West Nile virus particles. Virology 2012, 433, 226-235.
55. Yasuda-Inoue, M., Kuroki, M., Ariumi, Y., Distinct DDX DEAD-box RNA helicases cooperate to modulate the HIV-1 Rev function. Biochem. Biophys. Res. Comm. 2013, 434, 803-808.
56. Chen, Y. C., Su, W. C., Huang, J. Y., Chao, T. C. et al., Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A. J. Virol. 2010, 84, 7983-7993.
57. Gallina, A., Simoncini, L., Garbelli, S., Percivalle, E. et al., Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein. J. Virol. 1999, 73, 1468-1478.
58. Pan, S. H., Tai, C. C., Lin, C. S., Hsu, W. B. et al., Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability. Carcinogenesis 2009, 30, 366-375.
59. Sun, D., Luthra, P., Li, Z., He, B., PLK1 down-regulates parainfluenza virus 5 gene expression. PLoS Pathogens 2009, 5, e1000525.
60. Lee, K. S., Park, J. E., Kang, Y. H., Kim, T. S., Bang, J. K., Mechanisms underlying Plk1 polo-box domain-mediated biological processes and their physiological significance. Mol. Cells 2014, 37, 286-294.
61. Vitour, D., Dabo, S., Ahmadi Pour, M., Vilasco, M. et al., Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS.J. Biol. Chem. 2009, 284, 21797-21809.
62. Fros, J. J., Liu, W. J., Prow, N. A., Geertsema, C. et al., Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J. Virol. 2010, 84, 10877-10887.
63. Summers, M. K., Pan, B., Mukhyala, K., Jackson, P. K., The unique N terminus of the UbcH10 E2 enzyme controls the threshold for APC activation and enhances checkpoint regulation of the APC. Mol. Cell 2008, 31, 544-556.
64. Hao, Z., Zhang, H., Cowell, J., Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker. Tumour Biol. 2012, 33, 723-730.
65. Akhrymuk, I., Kulemzin, S. V., Frolova, E. I., Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II. J. Virol. 2012, 86, 7180-7191.
66. Cramer, P., Armache, K.-J., Baumli, S., Benkert, S. et al., Structure of eukaryotic RNA Polymerases. Ann. Rev. Biophys. 2008, 37, 337-352.
67. Weekes, M. P., Tomasec, P., Huttlin, E. L., Fielding, C. A. et al., Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 2014, 157, 1460-1472.
68. Vizcaino, J. A., Cote, R. G., Csordas, A., Dianes, J. A. et al., The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2013, 41, D1063-D1069.